Busan, South Korea

Tae Ho Hwang

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Tae Ho Hwang: Innovator in Oncolytic Virus Research

Introduction

Tae Ho Hwang is a prominent inventor based in Busan, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research on oncolytic viruses. With a total of 3 patents, Hwang's work focuses on developing advanced therapeutic methods for combating cancer.

Latest Patents

Hwang's latest patents include groundbreaking inventions that enhance the efficacy of cancer treatments. One of his notable patents is titled "Modified oncolytic vaccinia viruses expressing a cytokine and a carboxylesterase and methods of use thereof." This patent describes compositions and combinations for simultaneous, separate, or sequential use, which includes an oncolytic vaccinia virus that expresses a cytokine and a carboxylesterase enzyme, along with a cancer co-drug for effective cancer treatment. Another significant patent is "Compositions and methods for viral embolization," which relates to oncolytic viruses used in transcatheter arterial viroembolization methods. This patent provides compositions that combine oncolytic viruses with biocompatible microparticles or hydrophilic polymer gel agents suitable for active embolization, aiming to debulk tumors effectively.

Career Highlights

Throughout his career, Tae Ho Hwang has worked with notable companies such as Sillajen, Inc. and Dongbu Hitek Co., Ltd. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative cancer therapies.

Collaborations

Hwang has collaborated with esteemed colleagues, including Nam Hee Lee and Euna Cho. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in cancer treatment.

Conclusion

Tae Ho Hwang is a distinguished inventor whose work in oncolytic virus research is paving the way for new cancer therapies. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…